| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Pnumocandin-BO
|
135575-42-7 |
纽莫康定 B
|
纽莫康定 B0;纽莫康定(肺囊康定)B0;纽莫康定 B0;纽莫康定;纽莫康定B0((肺囊康定);卡泊芬净中间体;卡泊芬净中间体(纽莫康定 B0)
|
C50H80N8O17 |
1065.21 | 629-746-0 |
|
H-ARG-LYS-ARG-SER-ARG-ALA-GLU-OH
|
81187-14-6 |
ARG-LYS-ARG-SER-ARG-ALA-GLU: RKRSRAE
|
ARG-LYS-ARG-SER-ARG-ALA-GLU: RKRSRAE
|
C35H67N17O11 |
902.01 | |
|
H-ARG-PHE-ALA-ARG-LYS-GLY-ALA-LEU-ARG-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN-OH
|
113731-96-7 |
ARG-PHE-ALA-ARG-LYS-GLY-ALA-LEU-ARG-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN
|
LEU-LEU-TYR-GLU-MET-LEU-ALA-GLY-GLN-ALA-PRO-PHE-GLU-GLY-GLU-ASP-GLU-ASP-GLU-LEU-PHE-GLN-SER-ILE-MET-GLU-HIS-ASN-VAL: LLYEMLAGQAPFEGEDEDELFQSIMEHNV
|
C93H159N35O24 |
2151.48 | |
|
(S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoic acid
|
28047-15-6 |
2 - [[2 - (4 -羟基苯基)乙酰基]氨基]戊二酸
|
N-苯乙酰基-L-谷氨酰胺;2-[[2-(4-羟基苯基)乙酰基]氨基]戊二酸;N-苯乙酰基-L-谷氨酰胺;N2-(2-苯乙酰基)-L-谷氨酰胺
|
C13H16N2O4 |
264.28 | |
|
FMRF-LIKE PEPTIDE
|
98495-35-3 |
GLP-ASP-PRO-PHE-LEU-ARG-PHE-NH2: GLP-DPFLRF-NH2
|
|
C44H61 N11 O10 |
904.02 | |
|
PAR-4 (1-6) amide (human)
|
245443-51-0 |
人PAR-4 (1-6) AMIDE肽
|
人PAR-4 (1-6)AMIDE肽
|
C28H42N8O8 |
||
|
PAR-4 (1-6) (human)
|
225779-44-2 |
H-甘氨酸-酪氨酸-脯氨酸-甘氨酸-谷氨酸-缬氨酸-OH
|
H-甘氨酸-酪氨酸-脯氨酸-甘氨酸-谷氨酸-缬氨酸-OH;人PAR-4 (1-6)肽
|
C28H41N7O9 |
619.67 | |
|
PANCREATIC POLYPEPTIDE, RAT
|
90419-12-8 |
ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR-GLU-THR-GLN-LEU-ARG-ARG-TYR-ILE-ASN-THR-LEU-THR-ARG-PRO-ARG-TYR-NH2
|
老鼠胰脏多肽,≥95% ;老鼠胰脏多肽;ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR-GLU-THR-GLN-LEU-ARG-ARG-TYR-ILE-ASN-THR-LEU-THR-ARG-PRO-ARG-TYR-NH2
|
C195H298N58O57S1 |
4398.87 | |
|
Palmitoyl tripeptide-5 triflate
|
623172-56-5 |
棕榈酰三肽-5
|
N2-(1-氧代十六烷基)-L-赖氨酰-L-缬氨酰-L-赖氨酸 2,2,2-三氟乙酸盐 (1:2);棕榈酰三肽-5;棕榈酰三肽-5;胶原肽;胶原肽;棕榈酰三肽-5;棕榈酰三肽-3;5;胶原肽;棕榈酰三肽-5;棕榈酰三肽-3;棕榈酰三肽-3
|
C37H67F6N5O9 |
839.946399 | |
|
Palmitoyl tetrapeptide-7
|
221227-05-0 |
棕榈酰四肽-7/棕榈酰四肽-3
|
(S)-2-[(S)-1-[(S)-5-氨基-5-氧代-2-(2-棕榈酰氨基乙酰氨基)戊酰基]吡咯烷-2-甲酰氨基]-5-[(二氨基亚甲基)氨基]戊酸;棕榈酰四肽-7;棕榈酰四肽-3;棕榈酰四肽-7;棕榈酰四肽-3原液;棕榈酰四胜肽-7;棕榈酰四肽-3
|
C34H62N8O7 |
694.90548 | |
|
Palmitoyl pentapeptide
|
214047-00-4 |
五胜肽
|
M基肽;棕榈酰五肽-3;棕榈酰五肽-4;美容五肽;棕榈酰五肽-4;棕榈酰五肽-3;焕颜肽;(2S,5S,8S,11S,14S)-5,14-双(4-氨基丁基)-8,11-双((R)-1-羟基乙基)-2-(羟甲基)-4,7,10,13,16-五氧-3,6,9,12,15-五氮杂三十九烷-1-酸;棕榈五肽;基肽;N2-(1-氧代十六烷基)-L-赖氨酰-L-苏氨酰-L-苏氨酰-L-赖氨酰-L-丝氨酸;美容五肽
|
C39H75N7O10 |
802.05 | 606-757-9 |
|
Palmitoyl Dipeptide-5 Diaminobutyloyl Hydroxythreonine Palmitoyl Dipeptide-6 Diaminohydroxybutyrate
|
883558-32-5 |
N2-(1-氧代十六烷基)-L-赖氨酰-L-缬氨酰-(2S)-2,4-二氨基丁酰基-L-苏氨酸二(三氟乙酸)盐
|
N2-(1-氧代十六烷基)-L-赖氨酰-L-缬氨酰-(2S)-2,4-二氨基丁酰基-L-苏氨酸二(三氟乙酸)盐;棕榈酰二肽-5;棕榈酰二肽-5 二氨基丁酰羟基苏氨酸
|
C39H70F6N6O11 |
912.997119 | |
|
PA (224-233), Influenza
|
271573-27-4 |
SER-SER-LEU-GLU-ASN-PHE-ARG-ALA-TYR-VAL
|
|
C53H80N14O17 |
||
|
H-ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG-OH
|
92915-79-2 |
ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG
|
|
C74H120N26O25 |
1773.9 | |
|
H-PHE-TYR-GLY-PRO-VAL-OH
|
85679-70-5 |
PHE-TYR-GLY-PRO-VAL
|
|
C30H39N5O7 |
581.66 | |
|
H-GLY-PHE-GLN-GLU-ALA-TYR-ARG-ARG-PHE-TYR-GLY-PRO-VAL-OH
|
89458-24-2 |
GLY-PHE-GLN-GLU-ALA-TYR-ARG-ARG-PHE-TYR-GLY-PRO-VAL
|
|
C75H104N20O19 |
1589.75 | |
|
Ornipressin
|
3397-23-7 |
鸟氨加压素
|
鸟氨酸加压素>99%;8-鸟氨酸加压素;保尔-8;鸟氨酸加压素;鸟加压素;醋酸鸟氨酸加压素 ORNIPRESSINACETATE;醋酸鸟氨酸加压素;鸟氨加压素
|
C45H63N13O12S2 |
1042.19 | 222-253-8 |
|
acetic acid,10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
|
79517-01-4 |
奥曲肽
|
奥曲肽;奥曲肽-多肽原料;奥曲肽-多肽制剂;醋酸奥曲肽>99%;奥曲肽杂质4
|
C49H66N10O10S2 |
1019.24 | 616-695-4 |
|
Octreotide acetate
|
83150-76-9 |
醋酸奥曲肽
|
奥曲肽;[R-(R^<*>^,R^<*>^)]-D-苯丙酰-L-半胱氨酰-L-苯丙酰-D-色胺酰-L-赖氨酰-1-苏氨酰-N-[2-羟基-1-(羟基甲基)丙基]-L-苏氨酰胺环(2→7)二硫化物;醋酸奥曲肽 OCTREOTIDEACETATE;醋酸奥曲肽;醋酸奥曲肽 83150-76-10
|
C49H66N10O10S2 |
1019.24 | 1533716-785-6 |
|
Nogo-66 (1-40)
|
475221-20-6 |
NEP1-4; NOGO EXTRACELLULAR PEPTIDE; 1-4
|
PubChem ID: 90488731;ARG-ILE-TYR-LYS-GLY-VAL-ILE-GLN-ALA-ILE-GLN-LYS-SER-ASP-GLU-GLY-HIS-PRO-PHE-ARG-ALA-TYR-LEU-GLU-SER-GLU-VAL-ALA-ILE-SER-GLU-GLU-LEU-VAL-GLN-LYS-TYR-SER-ASN-SER-NH2;AC-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2;NEP1-40;NOGO-66 (1-40);NOGO-66 (1-40) ANTAGONIST PEPTIDE;NOGO EXTRACELLULAR PEPTIDE, 1-40;M.W. 4625.11 C206H324N56O65
|
药智官方微信
药智官方微博
